Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate
(26)
- Computing and Computational Sciences Directorate (38)
- Energy Science and Technology Directorate (223)
- Fusion and Fission Energy and Science Directorate (24)
- Information Technology Services Directorate (3)
- Isotope Science and Enrichment Directorate (7)
- National Security Sciences Directorate (20)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate
(135)
- User Facilities (27)
Researcher
- Srikanth Yoginath
- James J Nutaro
- Pratishtha Shukla
- Sudip Seal
- Alice Perrin
- Ali Passian
- Brian Sanders
- Bryan Lim
- Christopher Ledford
- Gerald Tuskan
- Harper Jordan
- Ilenne Del Valle Kessra
- Isaiah Dishner
- Jeff Foster
- Jerry Parks
- Joel Asiamah
- Joel Dawson
- John F Cahill
- Josh Michener
- Liangyu Qian
- Michael Kirka
- Nance Ericson
- Pablo Moriano Salazar
- Patxi Fernandez-Zelaia
- Paul Abraham
- Peeyush Nandwana
- Rangasayee Kannan
- Ryan Dehoff
- Tomas Grejtak
- Varisara Tansakul
- Vilmos Kertesz
- Xiaohan Yang
- Yan-Ru Lin
- Yang Liu
- Ying Yang
- Yiyu Wang

Enzymes for synthesis of sequenced oligoamide triads and tetrads that can be polymerized into sequenced copolyamides.
Contact
To learn more about this technology, email partnerships@ornl.gov or call 865-574-1051.

A new nanostructured bainitic steel with accelerated kinetics for bainite formation at 200 C was designed using a coupled CALPHAD, machine learning, and data mining approach.

Digital twins (DTs) have emerged as essential tools for monitoring, predicting, and optimizing physical systems by using real-time data.

Simulation cloning is a technique in which dynamically cloned simulations’ state spaces differ from their parent simulation due to intervening events.

Detection of gene expression in plants is critical for understanding the molecular basis of plant physiology and plant responses to drought, stress, climate change, microbes, insects and other factors.

High strength, oxidation resistant refractory alloys are difficult to fabricate for commercial use in extreme environments.

Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).